SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Thyrocare Technologies informs about execution of BTA

30 Aug 2024 Evaluate

Thyrocare Technologies has informed that the Company has entered into Business Transfer Agreement (‘BTA’) on August 30, 2024, around 11.00 am with, Vimta Labs, by which the Company would be acquiring Vimta’s diagnostic and pathological services business as a going concern (on a slump sale basis). Completion of the said acquisition is subject to fulfilment of the Conditions Precedent (‘CP’). Details required under Regulation 30 of the Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are given in the Disclosure Sheet attached as Annexure - 1 to this Letter.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

387.85 -4.75 (-1.21%)
21-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×